GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO.NS
2,698.35 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | GlaxoSmithKline Pharmaceuticals Limited |
Symbool | GLAXO.NS |
Munteenheid | INR |
Prijs | 2,698.35 |
Beurswaarde | 457,116,680,100 |
Dividendpercentage | 1.59% |
52-weken bereik | 1,385.05 - 3,088 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Bhushan Akshikar |
Website | https://india-pharma.gsk.com |
An error occurred while fetching data.
Over GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)